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ABSTRACT
PREVALENCE OF AVOIDANT/RESTRICTIVE
FOOD INTAKE DISORDER AND ASSOCIATION WITH NUTRITION STATUS IN
PATIENTS WITH INFLAMMATORY BOWEL DISEASES
by Emily R. Yelencich
There is a large body of research on the relationship between inflammatory bowel
disease (IBD) and diet; however, few conclusive, generalizable recommendations have
been determined. Regardless, IBD patients often alter their normal dietary intake, which
is concerning considering the prevalence of malnutrition in the IBD population.
Avoidant/restrictive food intake disorder (ARFID) is a feeding disorder that was recently
added to the Diagnostic and Statistical Manual of Mental Disorders and its prevalence
and impact on the nutritional status of IBD patients has not previously been described. In
this study ARFID risk was measured using the Nine-Item ARFID Screen and in the 161
outpatient, adult IBD participants 17% were at ARFID risk. Participants who avoid food,
regardless of disease status, had significantly higher ARFID risk scores than those who
do not avoid food. Participants who reported symptoms of diarrhea, pain, no appetite, and
fullness were significantly more likely to be at ARFID risk than those who did not.
Nutritional risk was measured using the Patient Generated-Subjective Global Assessment
(PG-SGA). ARFID risk score and nutritional risk score were positively correlated (rs=
0.196, P = 0.024), indicating that participants with a higher ARFID risk score were also
at risk for malnutrition. These results demonstrate that IBD patients should be regularly
screened for malnutrition and food avoidance, endorsing the critical role of a registered
dietitian as part of the IBD patient care team.
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CHAPTER 1
Literature Review
Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory illness that
encompasses two diagnoses: Crohn’s disease (CD) and ulcerative colitis (UC). There is
no cure for CD or UC and the best outcome for people with IBD is to remain in
remission, while managing uncomfortable and disruptive functional gastrointestinal
symptoms. Disease etiology and status in IBD is multifactorial and influenced by a
combination of genetic and environmental factors (Nahikian-Nelms, 2006). One of the
primary environmental factors that people with IBD can manipulate is diet. While many
diets have been suggested for the management of functional gastrointestinal symptoms
and disease management, there is a lack of easily accessible, conclusive, dietary
recommendations on which patients can make dietary choices. Even so, it is well
documented that people with IBD believe that their dietary choices influence their disease
status (Jowett et al., 2004; Limdi, Aggarwal, and McLaughlin, 2016; Zallot et al., 2013).
This leads patients with IBD to alter their dietary intake based on advice from the internet
(Marsh et al., 2019; Tinsley et al., 2016; Zallot et al., 2013) and under the direction of
clinical providers who do not always feel they have sufficient nutrition care resources or
adequate nutrition training (Raman, & Coderre, 2009; Scolapio, Buchman, & Floch,
2008; Tinsley et al., 2016). When this independent, unsupervised approach at dietary
intake is combined with confusion about what defines the most appropriate diet for IBD,
patients run the risk of developing restrictive eating behaviors that can result in deficient
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nutritional intake, increasing their risk for malnutrition (Vidarsdottir, Johannsdottir,
Thorsdottir, Bjornsson, & Ramel, 2016). This review will present research about diet and
IBD onset and disease course, specific diets for IBD treatment and management, and the
dietary beliefs, disordered eating behaviors and eating disorders, and nutritional risks of
people with IBD.
Inflammatory Bowel Disease Etiology
In both CD and UC, the delicate homeostasis of the gastrointestinal immune system is
compromised, leading to varying degrees of intestinal inflammation (Kim, & Cheon,
2017). Due to the multifactorial nature of IBD, the exact etiology has not been identified;
however, according to the Crohn’s and Colitis Foundation of America (2014), the
predominant theory is that a disturbance in the normal immune system response leads to a
dysfunctional immune system attack on the healthy microbiota in the intestine, leading to
chronic intestinal inflammation. While it is difficult to determine the exact combination
of factors that lead to this abnormal immune response, it is clear that people with a
genetic predisposition are more susceptible to developing IBD in response to a
combination of environmental factors. Environmental factors include diet, smoking,
antibiotic treatment, geography, and stress (Ananthakrishnan, 2015). Research has shown
that dietary factors can contribute to the development of IBD by altering the composition
of the gut microbiota and by directly regulating gastrointestinal immune cells (Sugihara,
Morhardt, & Kamada, 2019). These disruptions can lead to an abnormal inflammatory
response, resulting in the development of CD or UC. Once the homeostasis of the
gastrointestinal immune cells and microbiota is compromised, dietary factors can further
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exacerbate or ameliorate the disease (Sugihara, Morhardt, & Kamada, 2019). The
complexity of the relationship between dietary intake, microbiota, and inflammatory
response makes studying the effects of diet on IBD complicated and important.
Impact of Diet on IBD
Diet and IBD onset. Most research on the relationship between diet and IBD has
focused on disease onset. In a literature review by Spooren et al. (2013), researchers
found 36 studies investigating diet and IBD onset, compared to six studies investigating
diet and disease relapse. Conclusions from these studies vary; however, they highlight
dietary factors that are associated with higher risk of developing IBD such as total fat,
protein, and sugar, and they suggest that a high intake of fruits and vegetables may be
protective against disease onset.
One area of research about dietary intake prior to disease onset is lipid intake. In Reif
et al. (1997), researchers calculated the relative risk of developing UC between the
highest and lowest tertiles of poly-unsaturated fatty acids (PUFA), mono-unsaturated
fatty acids (MUFA), and cholesterol intake. They found that people in the highest tertile
of PUFA, MUFA, and cholesterol intake were 6.54, 3.66, and 5.57 times more likely to
develop UC, respectively, than those in the lowest tertile. In Geerling et al. (2000),
researchers confirmed Reif et al. (1997), finding that people in the highest tertile of
PUFA and MUFA intake were 5.1 and 33.9 times more likely to develop UC,
respectively, compared to those in the lowest tertile intake.
There are many types of PUFA and John et al. (2010) focused on the association of
two omega-3 PUFAs with disease onset: eicosapentaenoic acid (EPA) and
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docosahexaenoic acid (DHA). Researchers found that people in the highest tertile of
DHA intake were 79% less likely to develop UC compared to people in the lowest tertile.
The odds ratio (OR) trend across tertiles was 0.47 (95% confidence interval (CI): 0.25–
0.89). Researchers did not find a significantly protective effect of intakes in the highest
tertiles of EPA or total omega-3 PUFA compared to intakes in the lowest tertiles. In a
large scale, prospective cohort study that investigated fatty acid intake and IBD onset,
Chan et al. (2014) also found a protective effect of DHA on the onset of CD, with a 94%
reduction in the odds of developing incident CD for participants with the highest quintile
of DHA intake and a significant OR trend across quintiles.
Inversely, research has shown high omega-6 PUFA intake increases risk of
developing both UC and CD (Amre et al., 2007; Tjonneland et al., 2009). Amre et al.
(2007) found that children with a high omega-6 intake were nearly twice as likely to
develop CD compared to healthy controls and Tjonneland et al. (2009) found that adults
with the highest intake of the omega-6 fatty acid, linoleic acid, were nearly two and a half
times more likely to develop UC. Multiple studies investigating the association between
high total omega-6 intake and the onset of UC have demonstrated a trend toward higher
risk; however, they have not reached statistical significance (Geerling et al., 2000;
Sakamoto et al., 2005).
Other studies that looked at dietary intake and the risk of developing IBD did not find
significant associations between IBD onset and lipid intake (Jantchou, Morois, ClavelChapelon, Boutron-Ruault, & Caronnel, 2010; Tragnone et al., 1995). These studies did
find significant results for different nutrients. Jantchou et al. (2010) found that individuals
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in the highest tertile for protein intake were 3.31 times more likely to develop IBD than
those in the lowest. Tragnone et al. (1995) also saw a significant difference in total
protein intake between people with IBD (91.3 standard deviation (SD) ± 18.6g) and
healthy controls (80.9 SD ± 15.5g) and Opstelten et al. (2018) concluded that IBD
patients consume an additional 3.5g of protein per day compared to healthy controls.
Conversely, a number of other studies did not find significant differences or increased
risk ratios between protein intake and disease onset (Geerling et al., 2000; Hart et al.,
2008; Sakamoto et al, 2005; Reif et al., 1997).
Tragnone et al. (1995) and Opstelten et al. (2018) also found a positive association
between IBD onset and the consumption of carbohydrates. Tragnone et al. (1995) found
that people with IBD consumed significantly more total carbohydrates (331.3 SD ±
89.3g), starches (202.6 SD ± 70.3g), and refined sugar (101.43 SD ± 37.08g) compared to
healthy controls (232.5 SD ± 67.9g, 126.8 SD ± 42.4g, 83.5 SD ± 30.6g, respectively).
Again, Opstelten et al. (2018) confirmed these findings, demonstrating that IBD patients
consumed an average of 10.1g of additional carbohydrates per day compared to healthy
controls. Other studies did not find significant differences or increased risk between
carbohydrate intake and disease onset (Geerling et al., 2000; Hart et al., 2008; Jantchou et
al., 2010; Sakamoto et al, 2005).
Spooren et al. (2013) reviewed 32 studies investigating the effects of fruit and
vegetable intake on IBD onset and found that over half did not find any significant
associations; however, 13 studies did show a protective effect. Compared to people with
a low intake of fruits and vegetables, Porro and Panza (1985) found that people with a
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high intake of fruits and vegetables had a relative risk of developing UC between 0.30
and 0.38. Similarly, Hansen et al. (2011) found that people who ate fruits daily were 61%
less likely to develop CD and 44% less likely to develop UC. People who ate vegetables
daily were 59% less likely to develop CD and 49% (95% CI: 0.31–0.84) less likely to
develop UC. Unlike the dietary constituents previously reviewed, none of the articles
reviewed by Spooren et al. (2013) showed an increased risk of developing IBD for people
with a high intake of fruits and vegetables.
These studies demonstrate the inconsistent evidence regarding the role of dietary
factors in the onset of IBD. The inconsistent results could be related to methodological
differences and the inaccuracy inherent in collecting dietary data. Methodologically,
studies used a variety of instruments for collecting dietary intake, from food frequency
questionnaires (FFQ), to 7-day food diaries. Each instrument has strengths and
limitations, and each will lead to different conclusions (Thompson et al., 2015). Another
methodological problem is that most studies use FFQs to measure the dietary intake of
participants; however, absolute intake cannot be reliably measured through this
instrumentation. Instead, dietary intake is ranked; however, there are no set standards,
across studies, for what constitutes a high, medium, or low intake. This complicates the
interpretation of how dietary factors impact risk of IBD onset and relapse. These studies
highlight the inconsistent results that contribute to confusion in the field for both medical
practitioners as well as IBD patients.
Diet and IBD relapse. Similarly, there are varying results in the limited research on
how diet impacts IBD disease course. In a cross-sectional study, Tasson et al. (2017)
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examined the association between the current diet and disease status of participants. They
found that participants with the highest intake of legumes and potatoes had a 79% lower
risk of active disease. This study did not account for disease course over time, or any
changes in dietary intake in response to disease course.
In a prospective study, Opstelten et al. (2018) followed IBD participants for two
years, monitoring them for disease relapse. Thirty percent of participants relapsed, and
researchers associated ‘high’ or ‘low’ intake of macronutrients with relapse. They found
that participants who consumed a diet high in total fat, saturated fat, and monounsaturated fat were 37%, 77%, and 63% less likely to relapse, respectively. Conversely,
participants with a high intake of dietary fiber were 3.65 times more likely to relapse.
Jowett et al. (2004) followed UC patients for one year to observe dietary intake and
relapse. They found that individuals in the highest tertile of all meat (excluding fish)
intake were 3.74 times more likely to relapse compared to those in the lowest tertile.
Individuals with a high consumption of red and processed meats were 6.88 times more
likely to relapse compared to those in the lowest tertile. Jowett et al. (2004) did not find
any significant differences between fat or carbohydrate intake and risk of relapse.
These studies each identify a different macronutrient that may be associated with a
higher risk of relapse. The inconsistent results may be due to similar methodological
differences in the research about diet and IBD onset. These findings confirm that the
complicated relationship between diet and IBD extends from disease onset throughout
disease course.
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Dietary Effects of Specific Diets on IBD
Even with varying results about the impact of diet on disease onset and relapse, there
is a collection of research investigating the impact of IBD specific diets on disease course
and symptom management. In their guidelines for clinical nutrition in IBD, the European
Society for Clinical Nutrition and Metabolism (ESPEN) delivered a strong consensus that
“there is no ‘IBD diet’ that can be recommended to promote remission in patients with
active disease” (Forbes et al., 2017). They also agreed that research does not support a
generalizable, optimal diet for maintaining disease remission (Forbes et al., 2017).
Additionally, in a review for the Academy of Nutrition and Dietetics Evidence Analysis
Library, weak/limited evidence was found to support the efficacy of medical nutrition
therapy for gastrointestinal disorders (excluding celiac disease); however, only one, poor
quality review article met the inclusion criteria for the review. In the absence of
evidenced based medical nutrition therapy guidelines, the Academy of Nutrition and
Dietetics’ Nutrition Care Manual offers some guidance to practicing dietitians. It advises
that the primary goals of nutrition intervention should be to identify impediments to
adequate oral intake, correct or compensate for malabsorption, and meet increased
nutritional requirements while correcting for nutritional deficiencies and losses. When a
patient is in an acutely active disease phase, their nutrient absorption, transit time, and/or
ability to consume food orally may be impaired. If a patient cannot meet their needs
orally, enteral or parenteral nutrition may be necessary; however, this treatment is not
intended to induce remission in adult IBD patients (Eiden et al., 2003; Forbes et al.,
2017). A patient in active disease who can consume food orally, should eat small,
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frequent meals that are low in fat and fiber and high in protein and calories, ultimately
aiming for a normal diet (Eiden et al., 2003). In disease remission, the Nutrition Care
Manual recommends adjusting the diet of a patient based on their changing
gastrointestinal function, prioritizing energy and protein intake to support weight
management and nutrient intake. While the Nutrition Care Manual does not provide
specific dietary recommendations on how to manage functional gastrointestinal
symptoms or on how to reduce the risk of relapse, researchers continue to explore how
adherence to particular diets such as the Specific Carbohydrate Diet, the low fermentable
oligo-, di-, mono-saccharides and polyols diet, and the anti-inflammatory diet impact
disease course and symptom presentation.
IBD and the Specific Carbohydrate Diet. The Specific Carbohydrate Diet (SCD)
aims to induce and maintain drug-free remission in IBD patients by eliminating the
consumption of disaccharides and most polysaccharides. The proposed mechanism for
the SCD is that people with IBD produce too much intestinal mucus, inhibiting
disaccharidases in the luminal brush border. This prevents the proper digestion and
absorption of disaccharides, leading to intestinal injury and functional gastrointestinal
symptoms (Gottschall, 1994). While the diet and pathway are not endorsed by any
professional dietetic organizations, there is evidence that the SCD impacts the
microbiome and can exacerbate or diminish inflammation (Kakodkar, Mikolaitis, Engen,
& Mutlu, 2013).
In studies on the SCD in the adult IBD population, results have shown a positive
effect. In a self-reported survey of 50 adults who self-treated their IBD with the SCD,
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66% experienced clinical remission after a mean diet duration of 9.9 months. Several
subjects also stopped corticosteroid therapy while on the SCD (Kakodar, Farooqui,
Mikolaitis, & Mutlu, 2015). In another study, 417 IBD patients in a SCD support group
participated in a self-reported survey. After two months of following the SCD 33% of
participants reported remission, and after both six and twelve months, 42% reported
remission. Of the participants who reported reaching remission, 13% reported that they
experienced remission in less than two weeks, 17% reported that it took from two weeks
to a month, 36% reported that it took from one to three months, and 34% reported that it
took more than three months. For individuals who reported reaching remission, 47%
reported an improvement in abnormal laboratory values (Suskind et al., 2016). While
these studies highlight and confirm the positive perception of the SCD, there have not
been rigorous, placebo-controlled studies to verify the efficacy of the diet.
IBD and the anti-inflammatory diet. The anti-inflammatory diet (IBD-AID) is
another IBD specific diet that is based on the tenets of the SCD and is not endorsed by
any professional dietetic organizations. The IBD-AID upholds the theory that consuming
lactose and refined or processed complex carbohydrates can lead to gastrointestinal injury
and inflammation. It also places an additional emphasis on the importance of pre- and
probiotics in gut health, balancing the composition of fatty acid intake, and ensuring
sufficient micronutrient intake based on individual assessment. It also suggests altering
food texture to reduce intact fiber and improve absorption.
The proper implementation of and adherence to this diet is difficult due to its multicomponent, individualized nature. This barrier was emphasized by the high withdrawal
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rate in a study from the researchers who developed the IBD-AID (Olendzki et al., 2014).
Initially dietitians met with 37 IBD patients about the IBD-AID; however, only 11
participants were included in the analysis due to withdrawal (13 participants) or
incomplete data (13 participants). The 11 participants (8 CD, 3 UC) who met the
inclusion criteria followed the IBD-AID for at least four weeks, recording their dietary
intake and symptoms. Participants with CD had a mean reduction of their Harvey
Bradshaw Index (HBI) score from 11 (range: 0–20) to 1.5 (range: 0–3), indicating that all
participants reached disease remission (HBI ≤ 4). Participants with UC had a mean
reduction of their Modified Truelove and Witts Severity Index (MTLWSI) score from 7
(range: 6–8) to 0, indicating that all participants reached disease remission (MTLWSI ≤
2). While these results suggest a promising effect of the IBD-AID, they should be
interpreted with skepticism due to the small sample size and lack of control/placebo
groups. Furthermore, the association of the researchers with and investment in the diet
may have impacted results by influencing the recruitment process or the level of dietary
guidance that participants received. More research, from unaffiliated groups is required
before the diet is recommended and implemented.
IBD and the low fermentable oligo-, di-, mono-saccharides and polyols diet.
While the SCD and IBD-AID eliminate complex carbohydrates, the low fermentable
oligo-, di-, mono-saccharides and polyols diet (LFD) takes the opposite approach,
restricting specific simple carbohydrates. Also, unlike the SCD and IBD-AID, the LFD is
not intended to be followed, comprehensively, in the long-term. Instead, it is intended to
be an elimination diet with a reintroduction period aimed at identifying dietary triggers
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unique to each individual. This diet significantly reduces or eliminates the intake of shortchain carbohydrates, fructose, lactose, fructans, polyols, and galacto-oligosaccharides.
These carbohydrates are poorly absorbed and highly fermentable, leading to functional
gastrointestinal symptoms like diarrhea, gas, and bloating (Gibson, & Shepherd, 2005).
Many studies have shown that the LFD successfully manages functional gastrointestinal
symptoms in people with irritable bowel syndrome (Böhn et al., 2015; de Roest et al.,
2013; Staudacher, Whelan, Irving, & Lomer, 2017). In an observational study by de
Roest et al. (2013), participants with irritable bowel syndrome responded to a symptom
severity survey that used a 7-point Likert scale to assess the impact of the LFD on
multiple functional gastrointestinal symptoms. Researchers found that adherence to the
LFD was associated with the significant improvement of bloating, abdominal pain, gas,
and diarrhea.
Because many people with IBD have functional gastrointestinal symptoms, the LFD
has also been tested on and prescribed to people with IBD. In an observational study
performed on an IBD cohort, 56% of participants on the LFD reported improvement in
their overall functional gastrointestinal symptoms, indicating that the LFD can be a useful
symptom management tool for people with IBD (Gearry et al. 2009). In another
prospective, intervention study, Pedersen et al. (2017) randomly assigned people with
IBD to the LFD or to a normal diet for six weeks, collecting irritable bowel syndrome
symptom severity surveys at baseline and after the intervention. Researchers found that
after six weeks, the LFD group showed a significantly lower median irritable bowel
syndrome symptom severity score (median: 115) than the normal group (median: 170).
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When analyzed by disease type, researchers saw a significant irritable bowel syndrome
symptom severity score improvement in participants with CD on the LFD (median: 58)
compared to participants with CD on the normal diet (median: 220). The irritable bowel
syndrome symptom severity score did not significantly improve for participants with UC
on the LFD (median: 120) compared to participants with UC on the normal diet (median:
141).
While symptom management is important for patients with IBD it does not
necessarily reflect the disease status of a patient or the ability of a diet to control disease
maintenance or relapse. While Pedersen et al. (2017) did not see a significant
improvement of irritable bowel syndrome symptoms in UC participants; the Simple
Clinical Colitis Index, used to measure UC disease activity, significantly decreased in the
LFD group (baseline: 3, week 6: 1). In the normal diet group, the UC disease activity did
not change (baseline: 2, week 6: 2). Crohn’s disease participants on the LFD did not
experience a significant reduction in their HBI disease activity score. This indicates that
the LFD may be more effective in disease management for IBD patients with UC than
CD. One factor that may have influenced these results was that there were fewer
participants with CD than UC and it is possible that there were not enough CD
participants to achieve sufficient power and observe a significant improvement in disease
activity. While research on the LFD demonstrates conditionally positive results for
symptom management and disease activity management, it is a very restrictive diet that
merits further research into the long-term effects on nutrition status in people with IBD.
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Dietary Beliefs and Eating Behaviors of People with IBD
Based on the complicated nature of the previously reviewed diets and the inconsistent
methodologies and conclusions, it is not surprising that the IBD patient population is
uncertain about the best diet to follow for their disease. Even with this confusion, it has
been shown that IBD patients do believe that diet plays a role in their disease course and
that they hold strong dietary beliefs.
In a study performed by Limdi et al. (2016) on 400 IBD patients, researchers found
that 48% of participants believed that diet could be an initiating factor for IBD and 57%
of participants identified diet as a potential cause of relapse. In a similar study, Zallot et
al. (2013) found that 57.8% of IBD participants believed that food could lead to IBD
relapse; however, only 15.6% of participants thought that food could initiate IBD.
Similarly, Jowett et al. (2004) found that 68% of UC participants believed that their
dietary choices impacted their disease and 39% believed that specific foods lead to
relapse. While a higher percentage of IBD patients hold beliefs about how food
negatively impacts their disease status, Limdi et al. (2016) also found that 16% of IBD
patients thought that specific foods could improve their IBD symptoms.
Jowett et al. (2004) found that the food groups dairy, fruits, and vegetables were most
commonly avoided due to the perception that they had a negative impact on disease
status. The food groups that were most commonly reported to be the most beneficial to
the disease status of participants were fruits, vegetables, breads, cereals, and potatoes.
Participants in Cohen et al. (2013) reported that yogurt and rice improved IBD symptoms
and identified 18 foods or food groups that exacerbate symptoms. Some of the most
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commonly reported, detrimental foods were non-leafy and leafy vegetables, spicy foods,
nuts, fried foods, milk, and red meat.
While IBD patients hold many beliefs about how food impacts their disease course,
this does not necessarily mean that they alter their diets based on those beliefs; however,
many studies have investigated eating behavior in the IBD population and have shown
that between 49-90% of IBD patients do avoid specific foods (Bergeron, Bouin, D’Aoust,
Lemoyne, & Presse, 2018; Holt, Strauss, & Moore, 2017; Jowett et al., 2004; Marsh et
al., 2019; Walton, & Alaunyte, 2014; Vidarsdottir et al., 2016). Similarly, Jowett et al.
(2004) found that 22% of participants ate more of the foods they perceived to help their
disease.
Cohen et al. (2013) also investigated the connection between food beliefs and eating
behaviors by comparing food frequency questionnaires of IBD participants to their food
beliefs. Results showed that participants do alter their intake based on the perceived
benefit or harm of a food or food group. Patients who reported that red meat, dairy, or
sugar exacerbated their symptoms had a significantly lower intake of those items, while
patients who reported that cereal, milk, fruit, or whole grains improved symptoms had a
significantly higher intake of those items. These studies provide foundational evidence
that dietary restriction is a relevant eating behavior in the IBD population.
Disordered Eating in the IBD Population
The fact that many IBD patients engage in restrictive eating behaviors indicates that
the population may be at a high risk for disordered eating and eating disorders (Quick,
Byrd-Bredbenner, & Neumark-Sztainer, 2013). Research on the prevalence of disordered
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eating in the IBD population is limited; however, using the Eating Attitudes Test eating
disorder screener, Wabich, Bellaguarda, Joyce, Keefer, and Kinsinger, (2020) found that
13% of IBD patients are at a high risk for an eating disorder. When IBD patient responses
to the Eating Attitudes Test screener were analyzed by gender, high eating disorder risk
increased to between 18–20% for female IBD patients (Satherley, Howard, & Higgs,
2016; Wabich et al., 2020).
In a retrospective study, Wotton, James, and Goldacre (2016) examined the
comorbidity of autoimmune disease and eating disorder by calculating the likelihood that
people who were admitted to the hospital for an eating disorder were prospectively
admitted again for an autoimmune disorder and vice-versa. Wotton et al. (2016)
calculated a risk ratio, comparing the likelihood that the control group, people who were
admitted to the hospital for “minor conditions,” were prospectively hospitalized for an
autoimmune disease or an eating disorder. Compared to the control group, females who
were initially admitted for anorexia nervosa were about two times more likely to be
hospitalized for UC and CD in the future (2.25 and 1.97, respectively). Females who
were initially admitted for CD were 2.82 times more likely than the control group to be
hospitalized for anorexia nervosa in the future and females who were initially admitted
for UC were 1.91 times more likely than the control group to be hospitalized for anorexia
nervosa in the future. These results show that severe eating disorders are present in
female IBD patients and that there may be a correlation between the two diagnoses.
When specified, the primary eating disorders that these studies investigated were
anorexia nervosa and bulimia nervosa; however, based on the knowledge that IBD
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patients engage in food avoidance and restrictive eating, they may also be at a high risk
for the eating disorder diagnosis, avoidant/restrictive food intake disorder (ARFID).
ARFID was introduced into the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) in 2013 to broaden the scope of what was previously known as feeding disorder
of infancy and early childhood. The new ARFID diagnosis is applicable to individuals of
any age whose avoidant/restrictive eating behaviors but lead to insufficient caloric and/or
nutrient intake, causing at least one of the following symptoms: weight loss, nutritional
deficiency, dependence on nutritional supplements, or psychosocial impairment. The
DSM-5 describes three categories that can lead to the symptoms of ARFID: avoidance of
many foods based on their sensory properties (“picky eating”), low appetite or limited
interest in eating, and fear of negative consequences, such as choking or vomiting from
eating (American Psychiatric Association, 2013). Clinical diagnostic criteria for ARFID
requires a disturbed eating or feeding experience that is not motivated by weight or body
image concerns and that results in one or more of the following outcomes: nutritional
deficiency as a result of insufficient food intake, significant weight loss, dependence on
enteral or oral supplements, or impaired psychological function. If a patient also has a
mental or physical illness, the feeding disturbance must exceed any feeding disturbances
that are typically associated with the condition or disorder. Finally, patients who do not
have sufficient food access or who have cultural practices that change eating patterns
should not be diagnosed with ARFID (Katzman, Norris, & Zucker, 2018).
Because of the limited amount of research on eating disorders in the IBD population
and the relatively new diagnostic criteria of ARFID, there are no studies that have looked
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at the prevalence of ARFID in IBD patients specifically; however, a case study from
Ilzarbe et al. (2017) highlights that this may be a relevant diagnosis that is overlooked in
the IBD population. The 20-year-old subject of the case study had a CD diagnosis and an
eating disorder not otherwise specified. Ilzarbe et al. (2017) found the patient to have
significant weight loss in the previous year and described her eating habits as restrictive,
explaining that the patient is more comfortable using enteral nutrition. They also
specified that the patient did not have body image disturbance or fear of gaining weight.
While the patient was diagnosed with eating disorder not otherwise specified, her
symptoms meet the criteria for ARFID, and this would have been an appropriate
diagnosis that may have led to a more targeted and effective treatment regimen. This case
study highlights the concurrent incidence of IBD and ARFID while also showing that
without awareness and screenings, ARFID goes undiagnosed.
In two studies that investigated the prevalence of ARFID in patients with GI
disorders, researchers found that between 12–21% of participants met the ARFID
diagnostic criteria (Harer, Jagielski, Riehl, & Chey, 2019; Zia, Riddle, DeCou, McCann,
& Heitkemper, 2017). Harer et al. (2019) retrospectively evaluated the medical charts of
adult gastroenterology patients who had been referred to gastroenterology behavioral
health providers and found that 12.6% met the criteria for ARFID. Of those that met the
ARFID criteria, 14.3% had an IBD diagnosis. Zia et al. (2017) measured the prevalence
of many eating disorders, including ARFID, in adults with functional gastrointestinal
disorders. Results showed that 21% of participants met the criteria for ARFID. These
studies confirm the theoretical framework that ARFID is a relevant diagnosis for patients
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with IBD and they affirm the need to investigate the prevalence of ARFID in the IBD
population specifically, especially considering that they are a population that is at a high
risk for impaired nutritional status.
To evaluate ARFID diagnosis Harer et al. (2019) retrospectively evaluated the
medical charts of participants, screening for DSM-5 ARFID diagnostic criteria. The
authors did not go into detail on the screening process; however, this retrospective
process could have missed critical elements that may have led to, or invalidated, an
ARFID diagnosis. For example, determining food access or cultural practices may not
have been possible the medical records of participants. In their adult cohort, Zia et al.
(2017) implemented the ARFID Canadian Pediatric Surveillance Program Questionnaire,
an instrument validated for use in a child population that may not have been appropriate
for the adult population of the study.
Another recent instrument that has been validated to screen for ARFID risk in an
adult population is the Nine Item Avoidant/Restrictive Food Intake Disorder Screener
(NIAS) (Zickgraf, & Ellis, 2018). The NIAS is structured based on the three domains of
eating disturbances in the DSM-5: avoidance of foods due to sensory properties, poor
appetite or limited interest in eating, and fear of negative consequences from eating. The
NIAS has been used to identify avoidant and restrictive eating behaviors in children,
adolescents, adults who are healthy, and adults who were previously determined to have
eating difficulties (Elkins, & Zickgraf, 2018; Zickgraf, & Elkins, 2018; Zickgraf, Ellis, &
Essayli, 2019). It has not been used in the IBD population; however, in a study of adult
patients with symptoms of gastroparesis and dyspepsia, the NIAS was used to screen for
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ARFID (Murray, Jehangir, Silvernale, Kuo, & Parkman 2020).
To establish a clinical cutoff score, Ellis, Zickgraf, Whited, and Galloway (2017)
implemented the NIAS in a general sample of college students and in a sample of adults
who were known to have eating difficulties. Participants completed the NIAS and an
ARFID Symptoms Checklist that explicitly assesses the DSM-5 ARFID diagnostic
criteria. Using a receiver operating characteristic curve analysis and the area under the
curve (AUC), researchers determined that the NIAS was a good screener for ARFID in
both the general and selected samples (AUCgeneral= 0.87, AUCselected= 0.80). In the general
sample a cutoff of 24 demonstrated good sensitivity (0.74) and specificity (0.84). In the
selected sample, a cutoff score of 28 demonstrated adequate sensitivity (0.71) and
specificity (0.68). Researchers hypothesized that the group selected for eating difficulties
required a higher cutoff score because the symptoms associated with their eating
difficulties may have added complexity to their cases that could not be accounted for by
the screener.
Malnutrition in the IBD Population
Malnutrition in IBD patients is a serious condition as it is associated with negative
outcomes such as increased risk of non-elective surgery, increased length of hospital stay,
and increased mortality (Forbes et al., 2017). Many studies, using a variety of
methodologies, have shown that malnutrition is prevalent in the IBD population. In one
study that used unintentional weight loss as an indicator for malnutrition, researchers
found that 68.4% of IBD patients with active disease met the criteria for malnutrition and
that 31.6% met the criteria for severe malnutrition (Mijač, Janković, Jorga, & Krstić
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(2010). Similarly, Benjamin, Makharia, Kalaivani, & Joshi (2008) found that 52.6% of
patients with active or quiescent CD could be classified as malnourished based on a
collection of anthropomorphic measurements. Benjamin et al. (2008) also found that
participants with active CD were 7.5 times likelier to be malnourished than participants
with quiescent CD.
While it is important to estimate the prevalence of malnutrition, these studies do not
identify any nutrients that are specifically associated with malnutrition in IBD. Filippi,
Al-Jaouni, Wiroth, Hébuterne, & Schneider (2006) investigated specific deficiencies by
collecting data on both dietary intake as well as serum nutritional biochemical markers in
participants with quiescent CD and a matched control group. From an analysis of 3-day
prospective food records that were completed by participants, researchers found that
female CD patients had significantly lower mean daily intakes of β-carotene, vitamins
B1, B6, and C, and magnesium and significantly higher daily intakes of zinc compared to
controls. Male CD patients had significantly lower mean daily intakes of β-carotene and
vitamin C. From the biochemical analysis, researchers found that 84% of participants had
low plasma concentration of vitamin C and copper, 77% had low plasma concentrations
of niacin and 65% had low plasma concentration of zinc. Using the Nutritional Risk
Index and albumin levels (Prasad et al., 2016), researchers found that 29% of participants
were at moderate or severe risk for malnutrition.
These studies demonstrate the prevalence of malnutrition in IBD, but they do not
specify the association with restriction. Given the evidence that people with IBD do
restrict their intake according to their dietary beliefs, it is reasonable to expect that they
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may have nutrient deficiencies secondary to their dietary restriction. Jowett et al. (2004)
addressed this question by looking at three high-risk nutritional factors for IBD patients
who restrict their diets: folate, calcium, and fiber. Researchers did not find a significant
difference in folate or fiber intake between participants who believed that foods rich in
folate or fiber (ex. legumes, vegetables) were detrimental and those who did not. Folate
sufficiency in the IBD population was confirmed when Marcil et al. (2019) measured
serum folate and found that only 2.6% of participants had abnormally low results. Jowett
et al. (2004) did find that participants who believed that dairy was detrimental had a
significantly lower median calcium intake compared to participants who did not hold this
belief. This study shows that food beliefs and eating behaviors can impact micronutrient
intake and the under-consumed micronutrients identified by Filipi et al. (2006) should
also be investigated.
One patient-reported screening instrument that identifies patients at nutritional risk
and is designed to reduce the burden of a comprehensive nutritional assessment in the
clinical setting is the Patient-Generated Subjective Global Assessment Short Form (PGSGA SF). The PG-SGA SF is a shortened version of the full-length Patient GeneratedSubjective Global Assessment which was developed as a continuous score with a low
score indicating well-nourished nutritional status and a high score indicating higher risk
of malnutrition (Jager-Wittenaar, & Ottery, 2017). The four areas of the PG-SGA SF
address: weight history and acute weight change, changes in dietary intake, symptoms
that have impacted dietary intake, and changes to activities and function. The full-length
PG-SGA has been validated to measure nutritional risk in in ambulatory oncology
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settings (Bauer, Capra, & Ferguson, 2002; Isenring, Bauer, & Capra, 2003), an internal
medicine ward (Pinho et al., 2017), and in non-oncology surgery patients (Huang et al.,
2014). Subsequently, the PG-SGA SF has been validated as an analogous tool to the
Patient Generated-Subjective Global Assessment (PG-SGA) for screening for nutritional
risk (Abbott, Teleni, McKavanagh, Watson, McCarthy, & Isenring, 2016; Gabrielson et
al., 2013). In their validation study on outpatient oncology patients, Gabrielson et al.
(2013) found a strong, significant correlation between the full-length PG-SGA and the
PG-SGA SF (r = 0.984, P < 0.001). They also found that, with a sensitivity of 93.8% and
a specificity of 77%, the PG-SGA SF is comparable to the full-length PG-SGA
(sensitivity: 0.97, specificity: 0.77). Possible PG-SGA SF scores range from 0–36 and
Gabrielson et al. (2013) found that the optimal cutoff score for capturing patients with
malnutrition was six or greater. While the PG-SGA has been used in IBD studies
(Casanova et al., 2017; Lim, Kim, Hong, & Kim, 2014), it has not been validated in an
IBD population.
Dietary Assessment Methodology in IBD
Many types of dietary assessment instrumentation have been used in the IBD
population. Dietary intake assessment is necessary to address research questions that
investigate diet and disease etiology, disease course, and symptom management. Dietary
intake must also be assessed when evaluating the dietary adherence of participants in
intervention studies. Researchers have not established one, universally accepted
methodology for evaluating dietary intake in any population and in the IBD literature
many methodologies have been used to assess dietary intake, including 24-hour recalls,
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FFQ, diet histories, and dietary records. In a review of 56 articles investigating diet and
IBD course (Table 1), twenty-six implemented FFQs, eight implemented diet recalls,
fourteen implemented diet records, four implemented dietary screeners, and six
implemented study designed instruments. Some instruments were validated in the study
population (Opstelten et al., 2018; Vagianos et al., 2016) while others were validated in
populations different from that of the study (Geerling et al., 2000; Gilman, Shanahan, &
Cashman, 2006; Vagianos et al., 2007). Some of the instruments were validated in the
nutritional outcome relevant to the study (Pedersen et al., 2017; Vernia et al., 2014) and
others were novel and not validated outside of their study (Kyaw et al., 2014; Magee et
al., 2005). Many studies also collected biochemical samples to verify participant intake of
the nutrient of interest and to investigate the nutrient status of participants (Gee, Grace,
Wensel, Sherbaniuk, & Thomson, 1985; Geerling et al., 2000; Papada, Amerikanou,
Forbes, & Kaliora, 2020; Ripoli, Miszputen, Ambrogini, & Carvalho, 2010;
Silvennoinen, Lamberg-Allardt, Karkkainen, Niemela, & Lehtola, 1996; Vagianos et al.
2007 ). For example, Vagianos et al. (2007) implemented a FFQ, food diary, and
biochemical sample to assess the specific nutrient intake and nutrient status of IBD
patients. Using this combination of instrumentation, researchers were able to associate
dietary intake with serum levels of micronutrients like folate, vitamin B12, and vitamin
B6. While serum levels of specific nutrients do not always reflect accurate nutrient status,
when it is feasible and appropriate, biochemical samples can add validation to dietary
assessment data. Overall, establishing a study design that gathers accurate, thorough
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dietary data is a challenge due to the need to collect extensive, detailed data without
overburdening participants.
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Table 1. Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Antioxidant:
Geerling, 2000a,
the Netherlands

Antioxidant;
Fat;
Habitual Diet

UC; CD (69)

Cross-sectional

FFQ;
Diet History

Validated in pregnant Dutch
population. Specific to fat and
antioxidant intake.

Calcium;
Vitamin D

CD (58)

Cross-sectional

FFQ

Validated in Irish population.

Kuwabara, 2009,
Japan

Calcium;
Vitamin D;
Vitamin K;
Habitual Diet

UC; CD (25)

Cross-sectional

1 Day Diet
Record

—

Lopes, 2014,
Brazil

Calcium;
Dairy

UC; CD (65)

Cross-sectional

FFQ

Validated for use in chronic
disease intervention studies.

Silvennoinen,
1996, Finland

Calcium;
Dairy

UC; CD (152)

Cross-sectional

FFQ

Validated in Finnish population.

Vernia, 2014,
Italy
Diet Adherence:
Berghouse, 1984,
UK

Calcium

UC; CD (187)

Cross-sectional

FFQ

Validated to measure calcium
intake in Italian population.

Diet
Adherence

UC, CD with
Ileostomies (10)

Case Cross-over

1 Day Diet
Record

—

Diet
Adherence

CD Remission
(22)

Prospective

FFQ

Validated in Japanese
population.

Calcium:
Gilman, 2006,
Ireland

Chiba, 2010,
Japan
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Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Kyaw, 2014, UK Diet
UC (112)
Randomized
FFQ
Study designed.
Adherence,
Control Trial
Habitual Diet
Maagaard, 2016,
Denmark

Diet
Adherence

UC; CD; IBS
(180)

Prospective

Study Designed
Questionnaire

Designed to measure adherence
to low FODMAP intervention
diet.

Marlow, 2013,
New Zealand

Diet
Adherence

CD (8)

Prospective

Food Diary &
Self-Reported
Dietary
Compliance

—

Olendzki, 2014,
USA

Diet
Adherence

UC; CD (27)

Case Series

Food Diary

—

Papada, 2020,
Greece

Diet
Adherence

CD (86)

Cross-sectional

FFQ

MedDiet scoring method

Fat; MUFA;
PUFA; Trans
FA
Fat;
Habitual Diet

CD (99)

Case-Control,
Cross-sectional

FFQ

Validated in Portuguese
population.

CD Remission
(76)

Prospective
Cohort

FFQ

Validated in Japanese
population.

Fiber;
Diet
Adherence

CD Active (18)

Randomized
Control Trial

Food Diary

—

Fat:
Ferreira, 2010,
Portugal
Tanaka, 2007,
Japan
Fiber:
Bartel, 2007,
Austria
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Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Brotherton, 2016, Fiber
UC Remission;
Prospective
Dietary Screener Validated 26-item Dietary
USA
CD Remission
Screener Questionnaire from the
(1,619)
National Cancer Institute.
Dhingra, 2017,
India

Fiber;
Habitual Diet

UC Remission
(97)

Prospective

FFQ; Qualitative
Fiber
Questionnaire

Pre-tested, open-ended, semiquantitative FFQ, developed
with guidelines from National
Institute of Nutrition,
Hyderabad, India.

Levenstein,
1985, Italy

Fiber;
Diet
Adherence

CD Active (52)

Prospective

1 Week Diet
Recall

—

Ritchie, 1987,
UK

Fiber;
Diet
Adherence;
Sugar

CD (178)

Intervention
Study

2 Day Food
Diary; Structured
Interview

—

FODMAP;
Diet
Adherence

UC; CD (52)

Retrospective

Structured
Interview

Study-Designed

Halmos, 2016,
Australia

FODMAP;
Diet
Adherence;
Fiber;
Habitual
Diet; Sugar

CD (9)

Randomized
Control Trial,
Blind, CrossOver

Food Diary

—

Pedersen, 2017,
Denmark

FODMAP;
Diet
Adherence

UC Remission;
CD Remission
(89)

Randomized
Control Trial

FFQ

Comprehensive Nutrition
Assessment Questionnaire

FODMAP:
Gearry, 2009,
Australia
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Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Food Avoidance:
Bergeron, 2018,
Canada

Food
Avoidance

UC; CD (245)

Cross-sectional

FFQ

Dietary History QuestionnaireII, Adapted for Canada.

Vagianos, 2016,
Canada

Food
Avoidance;
Habitual
Diet; Sugar

UC; CD (256)

Longitudinal

Canadian Health Measures
Survey; Study Designed Food
Avoidance and Sugar Intake
Questionnaires

Walton, 2014,
UK

Food
Avoidance;
Habitual Diet

UC (93)

Cross-sectional

FFQ; Food
Avoidance
Questionnaire;
Sugar Intake
Questionnaire
24-Hour Recall;
Questionnaire

Habitual Diet

CD (112)

Cross-sectional

24-Hour Recall;
FFQ

Validated to measure energy and
fat intake of affluent Northern
Indian population.

BuenoHernandez, 2015,
Mexico

Habitual Diet

UC (233)

Cross-Sectional;
Prospective

Study-Designed
Questionnaire

Designed and Validated in
Study.

Cohen, 2013,
USA

Habitual Diet

UC; CD (2,329)

Cross-sectional

Dietary Screener

Filippi, 2006,
France

Habitual Diet

CD Remission
(54)

Cross-sectional

3-Day Food
Record

Validated 26-item Dietary
Screener Questionnaire from the
National Cancer Institute.
—

Gee, 1985,
Canada

Habitual Diet

UC; CD (114)

Cross-sectional

48-Hour Recall

Habitual Diet:
Benjamin, 2008,
India
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Study-Designed Questionnaire

—

Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Guerreiro, 2007,
Habitual Diet CD Remission
Cross-Sectional,
FFQ
FFQ validated in Portuguese
Portugal
(78)
Case-Control
population.
Han, 2020, USA

Habitual Diet

UC; CD (454)

Cross-sectional

Dietary Screener

Imes, 1987,
Canada
Joachim, 1999,
Canada

Habitual Diet

CD (137)

Prospective

Habitual Diet

UC; CD (60)

Cross-sectional

48-Hour Recall;
Food Diary
FFQ

Jowett, 2004, UK

Habitual Diet

UC (183)

Prospective

FFQ

Validated in UK population.

Jowett, 2004, UK

Habitual Diet

UC (183)

Prospective

FFQ

Validated in UK population.

Kakodkar, 2015,
USA

Habitual Diet

UC Remission;
CD Remission
(50)

Case Series

3-Day Food
Record

—

Komperød,
2017, Norway

Habitual Diet

CD Remission
(12)

Cross-sectional;
Prospective

Food List
Questionnaire

Study-Designed.

Lim, 2014,
Korea
Magee, 2005,
UK

Habitual Diet

UC; CD (41)

Cross-sectional

24-Hour Recall

—

Habitual Diet

UC (81)

Cross-sectional

7-Day Validated
Diet History

Study-Designed.

Opstelten, 2018,
the Netherlands

Habitual Diet

UC; CD (165)

Cross-sectional;
Longitudinal

FFQ

Adapted from validated FFQ.

Ripoli, 2010,
Brazil

Habitual Diet

UC (65)

Longitudinal

3-Day Food
Record; FFQ

No citation for FFQ.
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Validated 26-item Dietary
Screener Questionnaire from the
National Cancer Institute.
122 item food list based on
Block FFQ

Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Tasson, 2017,
Habitual Diet UC; CD (103)
Cross-sectional
FFQ
Adapted from EPIC-Norfolk
Italy
FFQ. Validated in small group
prior to study.
Triggs, 2010,
New Zealand

Habitual Diet

CD (446)

Cross-sectional

Food List
Questionnaire

Study-Designed.

Urbano, 2013,
Brazil

Habitual Diet

UC Remission
(59)

Cross-sectional

24-Hour Recall

Multi-pass method.

Vagianos, 2007,
Canada
Vidarsdottir,
2016, Iceland

Habitual Diet

UC; CD (126)

Cross-sectional

FFQ; Food Diary

Habitual Diet

UC; CD (78)

Cross-sectional

Wada, 2015,
Japan

Habitual Diet

UC; CD (388)

Cross-sectional

3-Day Food
Record; StudyDesigned
Questionnaire
Diet History
Questionnaire

Validated for fat and calcium
intake of menopausal women.
—

Weng, 2019,
China

Habitual Diet

UC; CD (322)

Cross-sectional;
Case-control

FFQ

Validated in Chinese population.

Iron; Habitual
Diet

CD Remission
(91)

Cross-sectional;
Case-control

7-Day Food
Diary

Validated through EPIC study.

Iron; Habitual
Diet

UC (103)

Cross-sectional

7-Day Food
Diary

Validated through EPIC study.

Iron:
Lomer, 2004,
UK
Tolkien, 2013,
Finland
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Validated in Japanese
population.

Table 1 (cont.). Articles reviewed for dietary assessment literature review, organized by primary outcome of interest.
Author, Year,
Outcome
Disease Type
Study Design
Assessment
Assessment Instrument
Country
(Sample Size)
Method
Miscellaneous:
Albenberg, 2019, Red &
CD Remission
Randomized
FFQ
Dietary History Questionnaire-II
USA
Processed
(213)
Control Trial
Meat; Fiber;
Habitual
Diet; Iron
Chiarello, 2009,
Brazil

Folate

UC; CD (10)

Prospective

24-Hour Recall

—

Skolmowska,
2019, Poland

Isoflavone

UC Remission
(56)

Cross-sectional

3-Day Food
Record

—

Suibhne, 2012,
Vitamin D
CD (151)
Cross-sectional,
FFQ
Ireland
Case-control.
CD: Crohn’s Disease; UC: Ulcerative Colitis; FFQ: Food Frequency Questionnaire
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Validated for calcium and
vitamin D intake.

Conclusion
This literature review describes the relationship between IBD and diet and
emphasizes the complexity of dietary assessment in the IBD populations. It also
highlights the challenge of reproducing generalizable dietary research due to suboptimal
dietary assessment methodologies and observational study designs. In order to draw
strong, evidence-based conclusions about the role of diet in the treatment and
maintenance of IBD, rigorous randomized controlled trials examining the efficacy of
diets like the SCD and LFD are necessary. Nevertheless, it is clear that people with IBD
hold strong dietary beliefs and alter their dietary intake in an effort to manage their
disease status and symptoms.
Due to the prevalence of malnutrition in the IBD population and the associated
negative outcomes, it is necessary to assess and quantify the extent to which the dietary
beliefs of IBD patients lead to disordered, restrictive eating behaviors and their impact on
nutritional status. Currently, there is no research investigating ARFID risk in the IBD
population, nor is there any research exploring the association between ARFID risk and
nutritional status. Chapter two will describe the prevalence of ARFID risk in the adult,
IBD population and it will examine the relationship between ARFID risk and nutritional
status. With more information on avoidant and/or restrictive eating behavior and its
association with malnutrition, health care professionals can equip themselves with tools
to provide targeted screenings, prevention, and treatment for high risk patients going
forward.
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CHAPTER 2
Journal Article
PREVALENCE OF AVOIDANT/RESTRICTIVE
FOOD INTAKE DISORDER AND ASSOCIATION WITH NUTRITION STATUS IN
PATIENTS WITH INFLAMMATORY BOWEL DISEASES
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Abstract
Background: Inflammatory bowel disease (IBD) patients often alter their normal dietary
behaviors. The prevalence of avoidant restrictive food intake disorder (ARFID) and its
impact on nutritional status among IBD patients are unknown. The purpose of this study
was to describe the prevalence of and risk factors for ARFID risk and to examine the
relationship between ARFID risk and nutritional status in IBD patients.
Methods: This cross-sectional study recruited adult IBD patients from an outpatient
clinic. ARFID risk was measured using the Nine-Item ARFID Screen (NIAS). Nutritional
status was measured with the Patient Generated-Subjective Global Assessment (PGSGA). Patient demographics, disease characteristics, and medical history were abstracted
from medical records.
Results: Of the 161 participants, 17% were at ARFID risk. Ninety-two percent avoid
food(s) during a flare, while 74% avoid food(s) in the absence of a flare. Participants who
avoid food, regardless of disease status had significantly higher ARFID risk scores
compared to those who do not avoid food. Patients who reported symptoms of diarrhea,
pain, no appetite, and fullness were significantly more likely to be at ARFID risk. There
was a positive relationship between ARFID risk and PG-SGA score (rs = 0.196, P =
0.024).
Conclusion: Avoidant eating behaviors are prevalent in IBD patients. The positive
correlation between ARFID risk score and PG-SGA score indicates that ARFID risk and
malnutrition risk are associated. These findings suggest that IBD patients should have
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regular visits with registered dietitians who can monitor both disordered eating behaviors
and malnutrition risk, directing appropriate nutrition intervention.
Keywords: inflammatory bowel disease, ulcerative colitis, Crohn’s disease,
avoidant/restrictive food intake disorder, malnutrition
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Background
Inflammatory bowel disease (IBD) is a chronic inflammatory illness that
encompasses two diagnoses: Crohn’s disease (CD) and ulcerative colitis (UC). Both
diseases are characterized by periods of heightened activity and remission. Increased
disease activity is commonly referred to as a flare, and signs and symptoms include
abdominal pain, diarrhea, bloody stool, and/or frequent bowel movements.1 There is no
cure for CD or UC and the best outcome for people with IBD is to remain in remission,
while managing uncomfortable and disruptive functional gastrointestinal symptoms.
Disease etiology and status in IBD is multifactorial and influenced by a combination of
genetic and environmental factors.1 One of the environmental factors that people with
IBD can manipulate is diet. While many diets have been suggested for the management
of functional gastrointestinal symptoms and disease management, there is a lack of easily
accessible, conclusive, dietary recommendations on which patients can make dietary
choices.2 Even so, it is well documented that people with IBD believe that their dietary
choices influence their disease status.3,4 This leads patients with IBD to limit their dietary
intake based on advice from the internet or general clinical practitioners.4,5 When this
independent, unsupervised approach at dietary intake is combined with confusion about
what defines the most appropriate diet for IBD, patients may alter their normal dietary
choices and behaviors and may run the risk of developing restrictive eating behaviors that
can result in deficient nutritional intake, increasing their risk for malnutrition.6,7
In 2013 avoidant/restrictive food intake disorder (ARFID) was introduced into the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) to broaden the scope of
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what was previously known as feeding disorder of infancy and early childhood. The new
ARFID diagnosis is applicable to individuals of any age whose avoidant/restrictive eating
behaviors lead to insufficient caloric and/or nutrient intake and cause at least one of the
following symptoms: weight loss, nutritional deficiency, dependence on nutritional
supplements, or psychosocial impairment.9 The DSM-5 describes three categories that
can lead to the symptoms of ARFID: avoidance of many foods based on their sensory
properties (“picky eating”); low appetite or limited interest in eating; and fear of negative
consequences, such as choking, vomiting, or other painful or uncomfortable symptoms
that might be associated with eating, such as abdominal pain and bloating.9-11 Because of
the recency with which ARFID was added to the DSM-5, there have not been any large
scale epidemiological studies conducted to measure the prevalence in the general
population10; however, studies have shown that the prevalence of ARFID in patients with
gastrointestinal disorders is 12–21%.11,12 While these studies demonstrate that ARFID is
prevalent in the gastrointestinal disorder population, they do not address how it impacts
the nutritional status of patients.
The association between restrictive eating and nutrition status is important to
investigate because IBD patients are at a higher risk for malnutrition. Studies have shown
that between 29–68% of IBD patients are malnourished6,13,14 and have significantly lower
mean daily intakes and plasma concentrations of essential micronutrients compared to
healthy controls.6
These studies demonstrate the prevalence of malnutrition in IBD, but they do not
address any association with restrictive eating behaviors. Given the evidence that people
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with IBD do restrict their intake, it is reasonable to expect that patients with ARFID may
be at an even higher risk for malnutrition. The three aims of this study were to describe
the prevalence of ARFID risk in the adult, IBD population, to identify risk factors for
ARFID, and to examine the relationship between ARFID risk and nutritional status. With
more information on the prevalence of restrictive eating and its association with
malnutrition, practitioners can equip themselves with tools to provide targeted screenings,
prevention, and treatment for high risk patients going forward.
Materials and Methods
Participant Recruitment
This cross-sectional study was conducted at the University of California, Los Angeles
(UCLA) Center for Inflammatory Bowel Diseases from October 2019 to March 2020.
English speaking, adult patients receiving care at this outpatient clinic with a confirmed
IBD diagnosis (Crohn’s disease, ulcerative colitis, or IBD-unknown) were invited to
participate in the study. Participants were excluded from the study if they had a medical
diagnosis of celiac disease, active anorexia nervosa or bulimia nervosa, an unmanaged
psychological disorder, alcohol abuse or if they were pregnant. Written consent was
obtained from eligible participants. The study was approved by UCLA’s Institutional
Review Board and a data sharing agreement was established between San José State
University and UCLA.
Demographic and Medical History Collection
Data were collected from participants by hardcopy survey before scheduled in-clinic
appointments. Medical data regarding the age, gender, race, ethnicity, substance use,

39

disease subtype (CD, UC, IBD-unknown), and disease duration of participants were
abstracted from electronic medical records. Current medication use was also identified in
electronic medical records and was categorized as aminosalicylates, steroids,
immunomodulators or biologics. CD location was classified as ileal, colonic, ileocolonic,
upper GI, or unknown and CD behavior was classified as inflammatory, structuring,
fistulizing, or perianal. UC extent was classified as rectum, left colon, pancolon, or
unknown. Participants were identified as having no flare, recent flare (within 60 days), or
active flare and previous small bowel resection, colectomy, or ileoanal anastomosis
pouch surgeries were recorded.
Assessment of Avoidant/Restrictive Food Intake Disorder Risk
Avoidant/restrictive food intake disorder (ARFID) risk was measured using a the
Nine Item Avoidant/Restrictive Food Intake Disorder Screen (NIAS) which has been
validated in a nationally representative subject pool, an undergraduate student population,
and in a population selected for eating difficulties.15 The screening tool is organized into
three specific domains of ARFID that have been identified by the DSM-5, each of which
is addressed by three questions. The three domains assess eating restriction due to picky
eating, poor appetite/limited interest in eating, and fear of negative consequences from
eating. Each domain includes three questions and the scores range from 0 to 15 max.
When compared to other instruments that measure picky eating, appetite, and fear, the
ARFID risk screening tool has high internal consistency (Cronbach’s α = 0.90), test-retest
reliability (ICC = 0.65, 95% CI: 0.56–0.72), and convergent/discriminant validity for
adults aged 18–65. Questions are based on a 6-point Likert scale with 0 indicating
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“strongly disagree” and 5 indicating “strongly agree.” Survey responses were totaled for
an ARFID risk score that ranged from 0–45. Ellis et al.16 demonstrated that a total cutoff
score of 24 showed good sensitivity (0.74) and specificity (0.84) for identifying a positive
ARFID diagnosis. Additional questions were added to the survey to provide more detail
about the eating behaviors of participants. One question asked whether the participant has
consistent access to food and another asked whether they make dietary choices based in
specific cultural practices. Participants were also asked “during a flare do you avoid any
of the following foods: lactose containing foods, spicy foods, alcohol, wheat products,
deep fried/fatty foods, caffeine, or other” and “during remission do you avoid any of the
following foods: lactose containing foods, spicy foods, alcohol, wheat products, deep
fried/fatty foods, caffeine, or other.” If participants answered yes to one or more foods,
they were categorized as avoiding food. If they answered no, they were categorized as not
avoiding food.
Assessment of Nutritional Status
Nutritional status risk was measured using an adapted version of the validated Scored
Patient-Generated Subjective Global Assessment Short Form (PG-SGA).17 The PG-SGA
is based on self-reported criteria and has been validated to measure nutritional risk in
ambulatory oncology settings,18 an internal medicine ward,19 and in non-oncology
surgery patients.20 The PG-SGA has four sections covering recent weight change,
changes in food intake, symptoms with possible nutrition impact, and activities and
functions and has been described elsewhere.17 Of importance to this study was the overall
PG-SGA score (0(low risk)–36(high risk)) which indicates malnutrition risk.17 Gabrielson
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et al.21 found that a cutoff score of six or greater had high sensitivity (0.938) and
specificity (0.776 ) and was optimal for capturing patients with confirmed malnutrition.
Percent weight loss over past month was calculated from the patient report of current
weight and weight from one-month prior on the PG-SGA. To determine nutrition impact
symptoms, responses to the third section of the PG-SGA were used. Participants were
asked to select symptom(s) that kept them from eating enough during the past two weeks
and were instructed to select all symptoms that apply. IBD related symptoms were
reviewed for this study and included: no appetite, just did not feel like eating; vomiting;
nausea; diarrhea; constipation; smells bother me; feel full quickly; fatigue; pain; and
other.
Data Analysis
All statistical analyses were performed using SPSS and results were considered
statistically significant when P < 0.05. Continuous variables were tested for normalcy
using the Shapiro-Wilk test. Parametric data were summarized as means (± standard
deviation (SD)) or percentages and non-parametric data were summarized as median
(interquartile range (IQR)). To test for significant differences between ARFID domains,
the Kruskal-Wallis test was performed. The Kruskal-Wallis test was also used to test for
differences in ARFID risk score across clinical characteristics (BMI, flare status, gender,
IBD type). Any significant differences were analyzed post-hoc using a Mann-Whitney U
test, adjusted with a Bonferroni correction. Multiple linear regression was used to
evaluate associations between clinical characteristics and ARFID risk score. Correlations
between total ARFID risk score, and measures of nutritional status were evaluated using
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the Spearman correlation coefficient. Nominal results were tested for dependence using
the chi-square test. If criteria for the chi-square test were not met the Fisher’s Exact test
was used.
Ethical Considerations
Consent was obtained from all participants and the ethics committee at UCLA
approved the study.
Results
Participant Demographics
One hundred and sixty-one patients were enrolled in the study, completed the ARFID
risk questions, and were included in this study. Of the 161 participants, 73 had CD
(45.3%), 83 had UC (51.6%), and 5 had IBD-unclassified (3.1%). Eighty-eight
participants were female (54.7%) and 73 were male (45.3%). The average age of
participants was 41.1 years (SD ± 15.5). The majority of participants were white (n =
114, 70.8%), 14 were Hispanic (8.7%), 3 were Asian (1.9%), and 6 were black (3.7%)
(Table 1). The mean duration of IBD diagnosis was 13.0 years (SD ± 11.6). The majority
of patients had no recent flare (n = 110, 68.3%), 11 (6.8%) patients had a flare within 60
days, and 40 (24.8%) patients had an active flare. Twenty-two (13.7%) participants
reported that they make dietary choices based in cultural practices. Fifty-four percent of
participants had a BMI in the normal range, 5.6% were underweight, and 40.4% of
participants were overweight/obese (mean 24.7; SD ± 4.6). BMI did not differ between
IBD types (Kruskal-Wallis H: 2.395, P = 0.302) (Table 2).
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TABLE 2. Demographic and Clinical Characteristics
n, (%)
Age
Gender
Female
Male

161 (100)
161 (100)
88 (54.7)

Underweight
Normal
Overweight
Obese

73 (45.3)
161 (100)
9 (5.6)
87 (54.0)
47 (29.2)
18 (11.2)

Disease Duration
IBD Type

159 (98.8)
161 (100)

Crohn’s disease
Ulcerative colitis
IBD-U
Race
Asian
Black

73 (45.3)
83 (51.6)
5 (3.1)
161 (100)
3 (1.9)
6 (3.7)

BMI

White
Other
Hispanic
Yes
No
CD Location
Ileal
Colon
Ileocolonic
Upper Gastrointestinal

114 (70.8)
38 (23.6)
161 (100)
14 (8.7)
147 (91.3)
73 (45.3)
21 (28.8)
16 (21.9)
35 (47.9)
1 (1.4)

CD Behavior
Inflammatory
Stricturing
Fistulizing

73 (45.3)
36 (49.3)
17 (23.3)
21 (28.8)

Perianal
Number of EIM

25 (15.5)
161 (100)

0
1
2+
Flare Status
No Recent Flare
Recent Flare within 60 Days
Active Flare

121 (62.1)
27 (16.8)
13 (8.1)
161 (100)
110 (68.3)
11 (6.8)
40 (24.8)
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Mean
(± SD)

Median (IQR)

41.1 (15.5)

38.3 (21.2)

24.7 (4.6)
17.2 (1.2)
22.2 (1.6)
27.1 (1.5)
34.0 (3.4)

23.8 (5.5)
17.5 (1.3)
22.3 (2.4)
27 (2.4)
33 (5.1)

13.0 (11.6)

10.0 (10.0)

TABLE 2 (cont.). Demographic and Clinical Characteristics
n, (%)
Mean
(± SD)

Median (IQR)

Current Medications
Aminosalicylates

64 (39.8)

Steroids
Immunomodulators

38 (23.6)
49 (30.4)

Biologics
Number of Prior Biologics
0
1
2+
Number of Surgeries
0
1
2
Surgical History
None
Small Bowel Resection
Colectomy
Ileal Pouch-Anal Anastomosis
Current Substance Use
Smoking
Drugs
Alcohol

88 (54.7)
161 (100)
109 (67.8)
23 (14.3)
29 (18.0)
161 (100)
134 (83.2)
18 (11.2)
9 (5.6)
134 (83.2)
15 (9.3)
14 (8.7)
7 (4.3)
6 (3.7)
20 (12.8)*
73 (45.3)

CD: Crohn’s disease; UC: ulcerative colitis; IBD-U: inflammatory bowel disease-unclassified; EIM:
extraintestinal manifestation
*n=156

Avoidant/Restrictive Food Intake Disorder Risk
The first aim of this study was to describe the prevalence of ARFID risk indicated by
a score of ≥ 2416 in an IBD population in Southern California. The median overall ARFID
risk score was 12 (IQR 7–20) with 17% of participants scoring ≥ 24 (Table 3). Of the
three domains that were assessed by the ARFID risk screening questionnaire, the fear of
negative consequences domain scored the highest with a median score of 5 (IQR 3–9)
and was significantly higher than the poor appetite domain which had a median score of 3

45

(IQR 0–6, P < 0.001) (Table 3). ARFID risk score was greater for participants who make
dietary choices based in cultural practices (median 18, IQR 9–26) compared to
participants who do not make dietary choices based in cultural practices (median 12, IQR
7–19, P = 0.49) (Table 3). Ninety-two percent of participants (n = 148) avoid one or more
foods when they are having a flare, while 74% (n = 119) avoid one or more foods in the
absence of a flare. In a flare, 54% (n = 87) of participants reported that they avoid lactose
containing foods, 71% (n = 114) reported that they avoid spicy foods, 70% (n = 112)
reported that they avoid alcohol, 38% (n = 61) reported that they avoid wheat products,
67% (n = 108) reported that they avoid deep fried/fatty foods, and 45% (n = 73) reported
that they avoid caffeine. In absence of a flare, 37% (n = 60) of participants reported that
they avoid lactose containing foods, 43% (n = 70) reported that they avoid spicy foods,
40% (n = 64) reported that they avoid alcohol, 23% (n = 37) reported that they avoid
wheat products, 39% (n = 62) reported that they avoid deep fried/fatty foods, and 22% (n
= 36) reported that they avoid caffeine. In both flare and no flare, participants commonly
wrote in that they avoid meat and vegetables.
The second aim of this study was to identify risk factors for ARFID. There were no
significant differences in ARFID risk score across IBD type, flare status, or gender
(Table 3). Participants who reported avoiding food during a flare and in the absence of a
flare had significantly higher ARFID risk scores (P < 0.001, P = 0.030, respectively)
(Table 3). Forty-six percent of participants reported one or more symptom that prevented
eating enough over the past two weeks. The most frequently reported problems were
fatigue (17%); no appetite, just did not feel like eating (16%); diarrhea (16%); pain
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(15%); feel full quickly (14%); and nausea (13%). Participants who responded
affirmatively to symptoms of diarrhea, pain, no appetite, and fullness were significantly
more likely to have an ARFID risk score above 24 (P = 0.009, P = 0.002, P ≤ 0 .001, P
≤ 0.001, respectively). In the multiple linear regression analysis, participants with prior
biologic use were found to have an ARFID score 3.3 points higher than participants with
no prior biologic use (95% confidence interval 0.30–6.3, P = 0.033). Age, gender, alcohol
consumption, disease activity, flare status, steroid use, and colon resection were not
found to be associated with higher ARFID risk scores.
TABLE 3. Comparison of Avoidant/Restrictive Food Intake Disorder (ARFID) Risk Score by
Domain and Total ARFID Risk Score Across IBD Patient Characteristics
Sample Size
Median
Test
(%)
(IQR)
Statistic
P
Total ARFID Risk Score
(minimum: 0 maximum: 45)

161 (100)

12 (7–20)

Picky Eating Score
(minimum: 0 maximum: 15)

161 (100)

4 (2–7)ab

Poor Appetite Score
(minimum: 0 maximum: 15)

161 (100)

3 (0–6)a

Fear of Negative Consequences Score
(minimum: 0 maximum: 15)

161 (100)

5 (3–9)b

Crohn’s disease

73 (45.3)

11.5 (7–19)

Ulcerative colitis

83 (51.6)

13 (7–20)

IBD-unclassified

5 (3.1)

11 (9–15)

110 (68.3)

12 (6.25–17)

Recent Flare within 60 Days

11 (6.8)

10 (8–15)

Active Flare

40 (24.8)

18.5 (8.75–26)

18.5

< 0.001

0.013

0.994

5.212

0.074

IBD Type

Flare Status
No Recent Flare
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TABLE 3 (cont). Comparison of Avoidant/Restrictive Food Intake Disorder (ARFID) Risk Score
by Domain and Total ARFID Risk Score Across IBD Patient Characteristics
Sample Size
Median
Test
(%)
(IQR)
Statistic
P
Gender
Female

88 (54.7)

14.5 (9–20)

Male

73 (45.3)

11 (6–18)

Yes

22 (13.7)

18 (9-26)

No

139 (86.3)

12 (7-19)

Yes

148 (91.9)

13 (8–20)

No

13 (8.1)

6 (5–11)

Yes

119 (73.9)

15 (9–20)

No

42 (26.1)

8 (5–12.75)

3.623

0.057

3.874

0.49

4.712

0.030

12.405

< 0.001

Makes Dietary Choices Based in Cultural
Practices

Avoids Food During Flare

Avoids Food in Absence of Flare

Kruskal-Wallis test was used to test for differences in ARFID risk score across clinical characteristics and across
domains.
ab
Values without a common superscript are significantly different as determined by Mann-Whitney U test and
adjusted with Bonferroni’s correction.

Nutritional Status
The third aim of the study was to determine the relationship between ARFID risk and
nutritional status. The PG-SGA questionnaire was completed by 133 participants and
nutritional risk was quantified. Twenty-nine percent of participants scored ≥ 6. The
median nutritional risk score was 2 (IQR 1–6) (Table 4). Results indicated a positive
linear relationship (rs(131) = 0.196, P = 0.024) between ARFID risk score and PG-SGA
score, indicating that participants who scored higher for ARFID risk also scored higher
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for nutritional status risk (Table 4). BMI was inversely correlated to ARFID risk score
(rs(159) = -0.161, P < 0.042); participants with a lower BMI score had a significantly
higher ARFID risk score (Table 4). Percent weight loss (median = 0, IQR -1.8–0.91) did
not differ based on IBD type (P = 0.549) or flare status (P = 0.062) and there was no
correlation between ARFID risk score and percent weight loss (rs(153) = 0.081, P =
0.821) (Table 4).
TABLE 4. Correlation of Avoidant/Restrictive Food Intake Disorder (ARFID) Risk Score to Measures
of Nutritional Status
Sample Size

Median (IQR)

Rho

P

Overall Nutritional Risk Score
(minimum: 0 maximum: 36)

133

2 (1–6)

0.196

0.024

BMI

161

23.8 (21.6–27.1)

-0.161

0.042

Percent Weight Loss

154

0 (-1.8–0.91)

0.018

0.821

Intake Score
(minimum: 0 maximum: 4)
133
1 (0–1)
0.039
Spearman’s Rho was used to measure correlation between ARFID risk score and measures of
nutritional status.

0.654

Discussion
The primary aim of this study was to describe the prevalence of ARFID risk, a
feeding disorder characterized by avoidant and/or restrictive eating behaviors in an
outpatient IBD population in Southern California. This study found that 17% of IBD
patients were at risk for ARFID, specifically, 16.4% of CD patients and 19.3% of UC
patients were at ARFID risk. No difference in ARFID risk was found between type of
IBD, sex, or flare status. In the general gastrointestinal disorder population, ARFID risk
has been reported between 12–21%.11,12 ARFID is associated with co-occurring anxiety
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disorders, gastrointestinal complications, and malnutrition and proper diagnosis can help
direct treatment and prevent nutritional and psychological complications.22 This was the
first cross-sectional study to look at the prevalence of ARFID risk in an IBD specific
population using a validated questionnaire. In line with previous research in the
gastrointestinal population8 and because the Nine-Item ARFID Screen has not previously
been used in the IBD population, a cutoff of 24 was selected for this study; however, in a
population selected for eating disturbances, researchers found that a score of 28 was
necessary to achieve adequate sensitivity and specificity.16 Future validation in the IBD
population would improve the utility of the screener in clinical practice.
Results show that 92% of IBD patients avoid foods when they are having a flare
compared to 74% who avoid foods in the absence of a flare. Cross-sectional studies have
found that between 49–90% of IBD patients avoid or restrict foods.3-5 This avoidance is
likely due to patient beliefs that certain foods exacerbate IBD symptoms.23,24 One-half of
our participants reported a nutrition impact symptom. The participants who reported that
at least one of the symptoms—diarrhea, pain, no appetite, or fullness—prevented them
from eating normally in the prior two weeks, were significantly more likely to have an
ARFID risk score of 24 or higher compared to those who did not. Previous research has
shown that IBD symptoms impact dietary intake5; however, this is the first study to draw
associations between IBD symptoms and ARFID risk score. Of the variables included in
the multilinear regression analysis, prior biologic use was the only clinical characteristic
that was associated with higher ARFID risk score. It is possible that the sample size in
this study was not large enough to detect a significant impact of the other variables that
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were included in the model. Although the majority of IBD patients are demonstrating
food avoidance, there is no evidence-based guideline recommending the avoidance of any
specific food to prevent or treat IBD flares.25 Based on clinical experience, the European
Society for Clinical Nutrition and Metabolism (ESPEN) guideline development group
agreed that all IBD patients should be regularly screened for malnutrition and
micronutrient deficiencies and that impairments should be corrected individually when
necessary.25 Evidence supports the monitoring and supplementation of serum calcium and
vitamin D levels for IBD patients in active disease and/or on steroid-treatments to help
prevent low bone mineral density.25 For UC patients in remission, there is also evidence
to support the use of probiotic therapy for the maintenance of remission; however,
probiotic therapy should not be used for maintenance of remission in CD.25 There was a
strong consensus, based on the clinical expertise of the ESPEN guideline group, that all
IBD patients in remission should undergo counseling by a dietitian to improve nutritional
therapy and to avoid malnutrition and nutrition-related disorders; although, the Academy
of Nutrition and Dietetics could not draw conclusions about the optimal frequency,
duration of nutrition professional visits, or medical nutrition therapy effectiveness for
gastrointestinal disorders.26
In the absence of strong evidence, the Academy of Nutrition and Dietetics Nutrition
Care Manual (NCM) offers some guidance to practicing clinicians, advising that the
primary goals of nutrition intervention should be to identify impediments to adequate oral
intake, correct or compensate for malabsorption, and meet increased nutritional
requirements, while correcting for nutritional deficiencies and losses.27 The NCM
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recommends IBD patients in active disease eat small, frequent meals that are low in fat
and fiber and high in protein and calories, and IBD patients in disease remission should
prioritize weight management and nutrient intake while making individualized
adjustments for gastrointestinal function.28 In a clinical practice expert review on the
treatment of functional gastrointestinal symptoms in patients with IBD, Colombel et al.29
endorse the implementation of a diet low in fermentable oligo-, di-, mono-saccharides
and polyols (FODMAP) for IBD patients in remission. The recommendation specifies
that because undernutrition is common in the IBD population and the low FODMAP diet
is restrictive, it should be introduced and monitored by a dietitian with special attention
placed on the provision of nutritional adequacy.29 This type of dietary management
requires the expertise of medical professionals to address patient-specific intolerances
while mitigating the risk of energy and nutrient deficiencies.
Due to the prevalence of malnutrition in the IBD population13,14 and the self-reported
evidence that IBD patients avoid or restrict foods in their diets3-5, this study sought to
investigate whether ARFID was relevant in the IBD population and if it was associated
with risk for compromised nutritional status. Malnutrition in IBD patients increases the
risk of non-elective surgery, increased length of stay, and mortality.25 Because
malnutrition is challenging to measure, this study investigated multiple markers of
nutritional status including weight status, percent weight loss, and the PG-SGA
malnutrition screener. One-third of the IBD patients in this study were found to be at risk
of malnutrition which aligns with previous reported prevalence rates of 29–68%.6,13,14
Unique to this study, higher ARFID risk was associated with higher malnutrition risk and
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lower BMI status; although, only 6% of patients had a BMI low enough to be categorized
as underweight and there was no association with recent weight loss and ARFID risk
score. This study did not evaluate all six characteristics that can be used to diagnose
malnutrition.30 Future studies should include a nutrition focused physical exam to
determine loss of muscle mass, subcutaneous fat, and fluid accumulation that may mask
malnutrition.31
Regardless of flare status, participants reported that they avoid lactose containing
foods, wheat products, meat, and vegetables, supporting avoidant dietary intake patterns
that have been identified in previous studies.32,33 Common nutritional deficiencies in IBD
patients that have been associated with food avoidance include vitamin D, calcium, iron,
zinc, vitamin B6, vitamin B12, and vitamin C.32,33 Foods that are avoided by IBD patients
such as dairy, meat, and raw fruits and vegetables are good sources of these essential
nutrients and patients who avoid these foods may be at an increased risk for nutrient
deficiencies.34 Nutrient deficiencies have been associated with increased risk of
osteoporosis, surgery, and hospitalization.35,36 In this study, dietary assessments were not
collected, thus the nutrient intake and adequacy of participants could not be determined.
The majority of participants in this study avoid one or more foods during a flare or in
remission. Our findings also show that IBD patients who report avoiding foods, whether
in a flare or in the absence of a flare, have significantly higher ARFID risk scores
compared to those who do not avoid foods. This indicates that IBD patient care should
include discussion about food avoidance and ARFID risk assessment. If a patient avoids
entire food groups, such as dairy, they should be referred to a registered dietitian as diet
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counseling has been shown to have an impact on the nutritional status of IBD patients37
and is recommended by the European Society for Clinical Nutrition and Metabolism.25 It
is well established that registered dietitian nutritionists are critical to the nutrition care of
individuals with eating disorders39 as they can perform nutrition focused physical
examinations, assess biochemical results, and interpret weight status, implementing
clinical judgement to direct interventions and mitigate impairments. According to
registered dietitians, Scarlata et al.40 in the irritable bowel syndrome population,
restrictive dietary interventions, such as the low FODMAP diet, are not universally
appropriate and are particularly risky for patients who are at risk for eating disorders.
They suggest that irritable bowel syndrome patients should be screened for eating
disorders and that patients who have maladaptive food avoidance would benefit from
coordinated care between registered dietitians and mental health providers. The results
from this study that demonstrate the prevalence of ARFID risk in the IBD population
show that maladaptive food avoidance is relevant and that the clinical practice
recommendation from Scarlata et al.40 is applicable to IBD patients as well. While this
may be time and resource intensive, individualization of dietary interventions is required
to ensure their appropriateness, minimize nutritional risk, improve disease outcomes, and
reduce the likelihood that maladaptive eating patterns and the associated risks are
exacerbated.
In the future, researchers should confirm the prevalence of ARFID in the IBD
population through clinical verification, assessing participants psychosocial impairment
such as work or school interference, social interference, and family interference as well
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as medical consequences such as ARFID related weight loss, reliance on supplemental
feeding, and ARFID related nutritional deficiency.9 There is also a need for controlled,
prospective studies to evaluate how ARFID impacts nutritional status or deficiencies.
Finally, evidence-based practices for the treatment of ARFID should also be established
through rigorous clinical trials.
In conclusion, this study establishes that IBD patients are at risk for ARFID and that
there is an association between ARFID risk and nutritional status. With this knowledge,
IBD patients should be screened for factors that were found to be associated with higher
ARFID risk score such as avoidant eating behaviors, low BMI, IBD symptoms like
diarrhea, pain, lack of appetite, and early satiety, and prior biologic treatment. Regular
ARFID screening of IBD patients would help direct appropriate dietary interventions for
disease and symptom management and could help identify early malnutrition risk,
leading to earlier intervention and reduced negative outcomes.
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CHAPTER 3
Summary and Recommendations
Summary
Previous research has explored the relationship between diet, inflammatory bowel
disease (IBD) etiology, and disease course; however, strong evidence-based practices for
IBD prevention or disease management are limited due to inconsistent, poor-quality
research (Forbes et al., 2017). As explored in chapter one, it is challenging to draw
generalizable conclusions about the impact of diet on IBD from studies that implement
inconsistent dietary assessment methodologies and observational study designs. Based on
the lack of high-quality research, experts do not endorse the universal application of one
diet pattern or the elimination of any specific foods for IBD prevention or management
(Forbes et al., 2017); however, previous research and this study demonstrate that IBD
patients do avoid or restrict foods (Limdi et al., 2016; Zallot et al., 2013). While avoidant
or restrictive dietary behaviors may be effective and safe for the symptom management
of some IBD patients, they could also increase their risk of malnutrition and/or nutrient
deficiency. It is also possible that avoidant eating behaviors could indicate or portend the
development of the feeding disorder avoidant/restrictive food intake disorder (ARFID),
making the recommendation of a restrictive diet like the low fermentable oligo-, di-,
mono-saccharides and polyols (FODMAP) diet, specific carbohydrate diet, or the antiinflammatory diet inappropriate.
This study aimed to describe the prevalence of ARFID risk, identify risk factors for
ARFID risk, and evaluate the relationship between ARFID risk and nutritional status in
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the IBD population. While this study could not diagnose ARFID, it was the first study to
demonstrate that a proportion of the IBD population is at risk for ARFID, with 17% of
the 161 participants scoring equal to or above the cutoff value on the Nine-Item ARFID
Screener instrument. Low body mass index (BMI), food avoidance regardless of disease
status, and prior biologic treatment were identified as possible ARFID risk factors based
on their association with higher ARFID risk scores. Participants who reported a
nutritional impact symptom of diarrhea, pain, no appetite, or feeling full quickly were
also significantly more likely to be at risk for ARFID. While these results do not
demonstrate the direction of the relationship between IBD symptoms and ARFID risk,
they do suggest a possible bi-lateral relationship between disease symptoms and
restrictive eating behaviors. This was the first study to investigate the relationship
between ARFID risk and nutritional status, finding that a higher ARFID risk score was
associated with a higher malnutrition risk score.
Recommendations
The prevalence of ARFID risk in the IBD population and its association with
increased nutritional risk, supports the recommendation that patients with IBD should be
automatically referred to registered dietitians. Regular malnutrition screenings for the
IBD population have been recommended elsewhere (Forbes et al., 2017) and this study
augments that recommendation, proposing that if there is evidence that a patient has
avoidant eating behaviors, the adequacy of their nutritional intake should be monitored
closely. Implementing regular ARFID screenings in clinical practice could help
practitioners easily identify patients with avoidant eating behavior and also help direct the
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most appropriate nutrition interventions from registered dietitians. Patients who
demonstrate avoidant eating behaviors may not be appropriate candidates for highly
restrictive dietary interventions as a highly restrictive diet could exacerbate avoidant
behaviors, leading to further food avoidance and increasing the risk for inadequate
nutritional provision, nutrient deficiencies, and/or malnutrition.
Due to the novelty of this area of research, there are many outstanding research
questions. First future research should confirm the prevalence of ARFID in the IBD
population through clinical verification, assessing psychosocial impairments and medical
consequences. There is also a need for controlled, prospective studies to evaluate how
ARFID diagnosis or risk impacts the nutritional status or specific nutrient deficiencies of
IBD patients. Finally, further research is necessary to establish strong evidence-based
guidelines for when it is appropriate to implement restrictive diets in the IBD population
and to determine evidence-based alternatives.
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